相关实验视频
Updated: Jun 2, 2025

09:11
Assays for Validating Histone Acetyltransferase Inhibitors
Published on: August 6, 2020
6.5K
基斯脱乙酶 (HDAC) 抑制剂在癌症中的结构修饰和前景
Yu Chen1,2, Jiahong Su1, Sha Li1
1Laboratory of Molecular Pharmacology, Department of Pharmacology, School of Pharmacy, Southwest Medical University, Luzhou, Sichuan, 646000, China.
Current medicinal chemistry
|January 14, 2025
概括
这项研究探讨了用于癌症治疗的增强质脱乙酶抑制剂 (HDACis). 结构修改和PROTAC技术旨在提高选择性并克服耐药性,以获得更好的临床应用.
科学领域:
- 在瘤学瘤学.
- 药用化学 医学化学
- 分子生物学分子生物学
背景情况:
- 基因组脱乙酶 (HDACs) 是癌症进展的关键调节剂.
- 基因组脱乙酶抑制剂 (HDACis) 通过抑制增殖和诱导亡,表现出广泛的抗瘤活性.
- 传统的HDAC抑制剂面临着非目标效应和耐药性的挑战.
研究的目的:
- 通过结构修改来增强HDAC抑制剂的选择性.
- 调查HDAC8和HDAC10的结构修改,双目标抑制剂及其影响.
- 探索HDAC抑制剂与蛋白解向嵌合体 (PROTAC) 技术的组合,以提高向特异性.
主要方法:
- 使用天然化合物的HDAC抑制剂的结构修改.
- 双目标抑制剂的设计.
- 将PROTAC技术与HDAC抑制剂相结合.
主要成果:
- 结构修改可以提高HDAC抑制剂的选择性.
- 双目标抑制剂和PROTAC结合的HDAC抑制剂显示出增强疗效的潜力.
- 目前HDAC抑制剂的临床应用受到耐药性的限制.
结论:
- 结构修改对于开发更有效的HDAC抑制剂至关重要.
- 克服耐药性和非目标效应是改善癌症治疗的关键.
- 对具有增强活性的新型HDAC抑制剂的进一步研究有必要进行临床转化.
相关概念视频
Histone Modification
3.4K
3.4K
Spreading of Chromatin Modifications
8.2K
The histone proteins in the nucleosomes are post-translationally modified (PTM) to increase or decrease access to DNA. The commonly observed PTMs are methylation, acetylation, phosphorylation, and ubiquitination of lysine amino acids in the histone H3 tail region. These histone modifications have specific meaning for the cell. Hence, they are called "histone code". The protein complex involved in histone modification is termed as "reader-writer" complex.
Writers
The writer...
Writers
The writer...
8.2K
Histone Variants at the Centromere
4.3K
Histone variants are the histone proteins with structural and sequence variations. These variants may be regarded as “mutant” forms that replace their canonical histone counterparts in the nucleosomes. Specific post-translational modifications on the histone variants enable further chromatin complexity and regulate tissue-specific gene expression. The most common histone variants are from histone H2A, H2B, and linker histone H1 families. However, several variants of histone H3...
4.3K
Inhibition of Cdk Activity
4.6K
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
4.6K
Covalently Linked Protein Regulators
6.8K
Proteins can undergo many types of post-translational modifications, often in response to changes in their environment. These modifications play an important role in the function and stability of these proteins. Covalently linked molecules include functional groups, such as methyl, acetyl, and phosphate groups, and also small proteins, such as ubiquitin. There are around 200 different types of covalent regulators that have been identified.
These groups modify specific amino acids in a protein....
These groups modify specific amino acids in a protein....
6.8K
Chromatin Modification in iPS Cells
1.6K
Chromatin modification alters gene expression; therefore, scientists can add histone-modifying enzymes, histone variants, and chromatin remodeling complexes to somatic cells to aid reprogramming into pluripotent stem (iPS) cells.
Compact chromatin makes reprogramming difficult. Enzymes, such as histone demethylases and acetyltransferases, are often added during reprogramming to loosen the chromatin, making the DNA more accessible to transcription factors. Molecules that inhibit histone...
Compact chromatin makes reprogramming difficult. Enzymes, such as histone demethylases and acetyltransferases, are often added during reprogramming to loosen the chromatin, making the DNA more accessible to transcription factors. Molecules that inhibit histone...
1.6K

